SepsisDx
A Platform Technology
Digital Biosciences is developing SepsisDx, a platform for rapidly detecting sepsis biomarkers in urine. Our technology is designed to meet the needs of low-resource environments. It is low-cost, portable, and battery powered.
Sensitive and Specific
SepsisDx is focused on an assay mechanism that offers high sensitivity and specificity without extensive development of new biochemical interactions. For this, we are using a sandwich immunoassay to detect sepsis biomarkers found in urine.
Point-of-Care
Blood draws are the standard detection mechanism for sepsis, but in low-resource settings blood analysis requires significant resources and is labor intensive. In these settings, the analysis of urine is considerably more practical for the early detection of sepsis.
Novel Technology
SepsisDx is a non-invasive, rapid, point-of-care technology that includes an assay microfluidic chip, a detector, and machine-learning decision support and will require minimal human interaction.